β-hydroxy β-methyl butyrate (hmb) enriched amino acid
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2021 (NCT04858412)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07275996 | N/A | Mar 10, 2026 | University of Burgos |
| NCT05525039 | N/A | Oct 31, 2022 | Abbott, Chinese University of Hong Kong |
| NCT04858412 | N/A | Apr 1, 2021 | The Cleveland Clinic |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abbott | For profit | 1 | 0 | 1 | 2022 |
| Chinese University of Hong Kong | Academic/Hospital | 1 | 1 | 1 | 2022 |
| The Cleveland Clinic | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Burgos | Academic/Hospital | 1 | 1 | 1 | 2026 |
4 organizations
Page 1 / 1